Telix Pharmaceuticals Ltd 20-F for FY2024
Telix Pharmaceuticals Ltd (TLX)
20-F
2025-02-24
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 20-F
Telix Pharmaceuticals Ltd filed this 20-F on February 24, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 783.21M AUD
- up 55.8% from 502.55M AUD a year earlier
- Net income
- 49.92M AUD
- up 858.0% from net income of 5.21M AUD a year earlier
- Diluted EPS
- 14.46 AUD
- up 798.1% from 1.61 AUD a year earlier